The Korean Journal of Medicine

  • 제87권6호
  • /
  • Pages.659-664
  • /
  • 2014
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

아스피린 및 비스테로이드성 항염증제 과민반응

Hypersensitivity to Aspirin and Nonsteroidal Anti-inflammatory Drugs

  • 김철우 (인하대학교 의학전문대학원 내과학교실)
  • Kim, Cheol-Woo (Department of Internal Medicine, Inha University School of Medicine)
  • 발행 : 2014.12.01
⟨ 이전 논문 다음 논문 ⟩

초록

Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) are the most widely used medications, based on their antipyretic, analgesic, and anti-inflammatory effects. However, both aspirin and NSAIDs cause hypersensitivity reactions through immunologic as well as non-immunologic mechanisms. Except for the rare single-NSAID-induced reaction, most hypersensitivity reactions show cross-reactive features to other NSAIDs regardless of their chemical structure. An accurate correct medical history is the most important diagnostic approach, whereas the roles of blood and skin tests are limited in the majority of cases of NSAIDs hypersensitivity. Although able to confirm the presence of a hypersensitivity reaction, an oral or bronchial provocation test should be performed only under the supervision of a skilled physician at a well-equipped institution. Avoidance of the causative NSAID and all cross-reactive NSAIDs is the cornerstone of management. Patients who require treatment with aspirin or NSAIDs can undergo aspirin desensitization. Genetic predisposition to hypersensitivity to NSAIDs have been demonstrated, but a clear understanding of the pathophysiologic and phenotypic diversity of these hypersensitivity reactions requires further studies, including functional ones.

키워드

참고문헌

  1. Kowalski ML, Makowska JS, Blanca M, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA# and GA2LEN/HANNA*. Allergy 2011;66:818-829. https://doi.org/10.1111/j.1398-9995.2011.02557.x
  2. Kim MH, Jung HY, Sohn MK, et al. Clinical features of adverse drug reactions in a tertiary care hospital in Korea. Korean J Asthma Allergy Clin Immunol 2008;28:35-39.
  3. Rew SY, Koh YI, Shin HY, et al. Reporting and clinical features of adverse drug reactions from a single university hospital. Korean J Asthma Allergy Clin Immunol 2011;31:184-191.
  4. Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 2013;68:1219-1232. https://doi.org/10.1111/all.12260
  5. Settipane RA, Constantine HP, Settipane GA. Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy 1980;35:149-154. https://doi.org/10.1111/j.1398-9995.1980.tb01730.x
  6. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328:434. https://doi.org/10.1136/bmj.328.7437.434
  7. Samter M, Beers RF Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968;68:975-983. https://doi.org/10.7326/0003-4819-68-5-975
  8. Kong JS, Teuber SS, Gershwin ME. Aspirin and nonsteroidal anti-inflammatory drug hypersensitivity. Clin Rev Allergy Immunol 2007;32:97-110. https://doi.org/10.1007/BF02686086
  9. Hope AP, Woessner KA, Simon RA, Stevenson DD. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2009;123:406- 410. https://doi.org/10.1016/j.jaci.2008.09.048
  10. Mourad AA, Bahna SL. Hypersensitivities to non-steroidal anti-inflammatory drugs. Expert Rev Clin Immunol 2014;10:1263-1268. https://doi.org/10.1586/1744666X.2014.946905
  11. Erbagci Z. Multiple NSAID intolerance in chronic idiopathic urticaria is correlated with delayed, pronounced and prolonged autoreactivity. J Dermatol 2004;31:376-382. https://doi.org/10.1111/j.1346-8138.2004.tb00688.x
  12. Setkowicz M, Mastalerz L, Podolec-Rubis M, Sanak M, Szczeklik A. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years. J Allergy Clin Immunol 2009;123:174-178. https://doi.org/10.1016/j.jaci.2008.09.005
  13. Sanchez Borges M, Capriles-Hulett A, Caballero-Fonseca F, Perez CR. Tolerability to new COX-2 inhibitors in NSAIDsensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol 2001;87:201-204. https://doi.org/10.1016/S1081-1206(10)62226-0
  14. Asero R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol 2003;111:1095-1098. https://doi.org/10.1067/mai.2003.1444
  15. Burnett T, Katial R, Alam R. Mechanisms of aspirin desensitization. Immunol Allergy Clin North Am 2013;33:223-236. https://doi.org/10.1016/j.iac.2012.11.003
  16. Rozsasi A, Polzehl D, Deutschle T, et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy 2008;63:1228-1234. https://doi.org/10.1111/j.1398-9995.2008.01658.x
  17. In KH, Asano K, Beier D, et al. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 1997;99:1130-1137. https://doi.org/10.1172/JCI119241
  18. Sanak M, Simon HU, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997;350:1599-1600. https://doi.org/10.1016/S0140-6736(05)64015-9
  19. Kim SH, Sanak M, Park HS. Genetics of hypersensitivity to aspirin and nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am 2013;33:177-194. https://doi.org/10.1016/j.iac.2012.10.003

피인용 문헌

  1. Successful sequential desensitization in a patient with drug hypersensitivity to three kinds of antiplatelet agents vol.4, pp.5, 2014, https://doi.org/10.4168/aard.2016.4.5.374
  2. 항혈소판 응집 억제제(ASTRIX, PLAVIX) 복약 이후 하지 혈종 발생 사례 보고 vol.38, pp.5, 2014, https://doi.org/10.22246/jikm.2017.38.5.641